Discover 2,121 paid clinical trials in Toronto, Ontario. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,121
Active & Responsive
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
for
Intestinal Neoplasms, Gastrointestinal Neoplasms,
Location: Toronto, Auburn NY, Camillus NY, East Syracuse NY,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07222800
Phase 3, Recruiting
Active & Responsive
Liquid Biopsy Evaluation and Repository Development at Princess Margaret
for
Cancer, Breast Cancer, Lung Cancer, Colon Cancer,
Location: Toronto
Sponsor: University Health Network, Toronto
Sex: All
Age: 18+
Code: NCT03702309
Recruiting
Active & Responsive
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
for
Triple Negative Breast Neoplasms
Location: Toronto, Oshawa, Montreal, Grand Rapids MI,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06841354
Phase 3, Recruiting
Active & Responsive
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Patients With Bladder Cancer (MK-2870-027)
for
Non-Muscle Invasive Bladder Cancer
Location: Toronto, Baltimore MD, Sherbrooke, Chicago IL, Tampa FL,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06637423
Phase 1, Phase 2, Recruiting
Active & Responsive
Study of Iberdomide, Bortezomib, Dexamethasone With Isatuximab Added on Demand for ND-NTE MM Patients
for
Multiple Myeloma
Location: Toronto, London, Montreal, Halifax, St. John's,
Sponsor: Canadian Myeloma Research Group
Sex: All
Age: 65+
Code: NCT05272826
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
for
Advanced Solid Tumors, Genital Neoplasm, Female,
Location: Toronto, Detroit MI, Columbus OH, Bethesda MD,
Sponsor: Marengo Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT05592626
Phase 1, Phase 2, Recruiting
Active & Responsive
FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery
for
Cervical Cancer
Location: Toronto, Quebec
Sponsor: University Health Network, Toronto
Sex: Female
Age: 18 - 40
Code: NCT04016389
Recruiting
Active & Responsive
Multicenter Clinical Trial of ST-02 for Ablation of Upper Tract Urothelial Carcinoma
for
Urothelial Carcinoma of the Renal Pelvis and Ureter,
Location: Toronto, London, Montreal, Halifax, Winnipeg, Vancouver
Sponsor: Peter Black
Sex: All
Age: 18+
Code: NCT06124976
Phase 2, Phase 3, Recruiting
Active & Responsive
AACR Adaptive Biomarker-Driven Organ Preservation Trial in Gastroesophageal Adenocarcinomas
for
Gastroesophageal Adenocarcinoma
Location: Toronto, New Haven CT, Houston TX, Los Angeles CA
Sponsor: American Association for Cancer Research
Sex: All
Age: 18+
Code: NCT07290985
Phase 2, Recruiting
Active & Responsive
A Substudy of Investigational Agents in Programmed Cell Death-1/Ligand 1 (PD-1/L1) Refractory Locally Advanced or Metastatic Urothelial Carcinoma (mUC) (MK-3475-04A)
for
Urothelial Carcinoma
Location: Toronto, Cleveland OH, Pittsburgh PA, New York NY,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT05562830
Phase 1, Phase 2, Recruiting
Active & Responsive
A Clinical Study of MK-4716 in People With Certain Solid Tumors (MK-4716-001)
for
Malignant Neoplasm
Location: Toronto, Montreal, New Brunswick NJ, Fairfax VA, Quebec,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07247110
Phase 1, Recruiting
Active & Responsive
Study of Adjuvant Darovasertib and Crizotinib in Participants With Primary Non-metastatic Uveal Melanoma
for
Uveal Melanoma
Location: Toronto, Philadelphia PA, Nashville TN, Scottsdale AZ
Sponsor: IDEAYA Biosciences
Sex: All
Age: 18+
Code: NCT07804186
Phase 3, Recruiting
Active & Responsive
ARC101 in Advanced Solid Tumors
for
Advanced Solid Tumor
Location: Toronto, Montreal, Grand Rapids MI, San Antonio TX,
Sponsor: Third Arc Bio
Sex: All
Age: 18+
Code: NCT06672185
Phase 1, Recruiting
Active & Responsive
A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia
for
Chronic Myeloid Leukemia,
Location: Toronto, The Bronx NY, New York NY, Houston TX,
Sponsor: Enliven Therapeutics
Sex: All
Age: 18+
Code: NCT05304377
Phase 1, Recruiting
Active & Responsive
A Study of Calderasib (MK-1084) in KRAS Mutant Advanced Solid Tumors (MK-1084-001)
for
Advanced Solid Tumors
Location: Toronto, Hamilton, Kingston, Grand Rapids MI,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT05067283
Phase 1, Recruiting
Active & Responsive
A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma